Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Inhaled High-molecular Weight Hyaluronan in Patients With Severe COVID19: Feasibility and Outcomes

NCT04830020 is registered in ClinicalTrials.gov with Campus Bio-Medico University as lead sponsor.

NCT NCT04830020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04830020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Inhaled High-molecular Weight Hyaluronan in Patients With Severe COVID19: Feasibility and Outcomes
Lead sponsor
Campus Bio-Medico University
Phase
Phase 2
Overall status
Completed
Start date
February 26, 2021
Completion date
September 30, 2021
Enrollment
180 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19